These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 4081686)
1. [Effect of amiodarone on stimulatory convertibility and degeneration into ventricular fibrillation of induced ventricular tachycardias in the pig]. Hottinger S; Mettler D; Leupi F; Gertsch M Schweiz Med Wochenschr; 1985 Nov; 115(45):1594-6. PubMed ID: 4081686 [TBL] [Abstract][Full Text] [Related]
2. Acute management of ventricular arrhythmias: role of antiarrhythmic agents. Singh BN Pharmacotherapy; 1997; 17(2 Pt 2):56S-64S; discussion 89S-91S. PubMed ID: 9085341 [TBL] [Abstract][Full Text] [Related]
3. Clinical experience with amiodarone for treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ; Prystowsky EN; Miles WM; Zipes DP Br J Clin Pract Suppl; 1986 Apr; 44():16-27. PubMed ID: 3089256 [No Abstract] [Full Text] [Related]
4. Effects of a new amiodarone-like agent, SR 33589, in comparison to amiodarone, D,L-sotalol, and lignocaine, on ischemia-induced ventricular arrhythmias in anesthetized pigs. Finance O; Manning A; Chatelain P J Cardiovasc Pharmacol; 1995 Oct; 26(4):570-6. PubMed ID: 8569217 [TBL] [Abstract][Full Text] [Related]
5. [Amiodarone and ventricular tachycardia]. Facquet J; Nivet M; Fontaine G; Vachon J; Bruhat M G Ital Cardiol; 1972; 2(1):185. PubMed ID: 5012013 [No Abstract] [Full Text] [Related]
6. [Effect of cordaron on the threshold of ventricular fibrillation in cats]. Stoliarchuk AA; Storozhuk BG Kardiologiia; 1982 Nov; 22(11):82-4. PubMed ID: 7154512 [TBL] [Abstract][Full Text] [Related]
7. [Effect of previous administration of amiodarone on the early incidence of ventricular fibrillation during experimental myocardial ischemia]. Spadaro J; Hashimoto LM; Franco RS; Bregagnollo EA; Tucci PJ Arq Bras Cardiol; 1984 Jan; 42(1):25-9. PubMed ID: 6743037 [No Abstract] [Full Text] [Related]
8. Amiodarone in the management of patients with ventricular tachycardia and ventricular fibrillation. Morady F; Scheinman MM; Hess DS Pacing Clin Electrophysiol; 1983 May; 6(3 Pt 1):609-15. PubMed ID: 6191299 [TBL] [Abstract][Full Text] [Related]
9. Intravenous amiodarone. Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909 [No Abstract] [Full Text] [Related]
10. [Value of provocation tests in the evaluation of the treatment of ventricular tachycardias with amiodarone]. Cassagneau B; Calazel J; Puel J; Massabuau P; Tournadre P; Fauvel JM; Bounhoure JP; Marin T; Narula OS Arch Mal Coeur Vaiss; 1984 Jul; 77(7):766-72. PubMed ID: 6433839 [TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of amiodarone in treatment of recurrent ventricular tachycardia and ventricular fibrillation. Heger JJ; Prystowsky EN; Zipes DP Am Heart J; 1983 Oct; 106(4 Pt 2):887-94. PubMed ID: 6613835 [TBL] [Abstract][Full Text] [Related]
12. Conversion of recent-onset atrial fibrillation or flutter with ibutilide after amiodarone has failed. Hennersdorf MG; Perings SM; Zühlke C; Heidland UE; Perings C; Heintzen MP; Strauer BE Intensive Care Med; 2002 Jul; 28(7):925-9. PubMed ID: 12122531 [TBL] [Abstract][Full Text] [Related]
13. Pharmacologic therapy for survivors of sudden death based on programmed stimulation. Roy D; Marchlinski FE; Doherty JU; Buxton AE; Josephson ME Cardiovasc Clin; 1985; 15(3):179-85. PubMed ID: 3914364 [No Abstract] [Full Text] [Related]
14. [The amiodarone-beta blockers combination could represent an alternative treatment in patients at risk for sudden death in which a benefit from implantable defibrillators has not been clearly demonstrated]. Alboni P Ital Heart J Suppl; 2002 Mar; 3(3):337-43. PubMed ID: 12040849 [TBL] [Abstract][Full Text] [Related]
16. [Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia]. Klein H Cardiologia; 1985 Jul; 30(7):487-92. PubMed ID: 3834995 [No Abstract] [Full Text] [Related]